The latest research study “Continuous Glucose Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global continuous glucose monitoring systems market reached a value of US$ 5.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.56 Billion by 2027, exhibiting a CAGR of 9.50% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market/requestsample
Continuous glucose monitoring systems (CGMS) are advanced glucose sensing and monitoring devices that measure, track and display the blood glucose levels of a patient. They consist of a glucose sensor inserted into the subcutaneous tissue that continuously measures the glucose concentration in the interstitial fluid or blood. They also have a transmitter attached to the sensor that transfers the data to a receiver, a wireless monitor, or a smartphone. These systems assist in providing a complete profile of diabetes, detecting patterns, and alerting highs and lows of blood sugar levels. As a result, CGMS is gaining traction over conventional glucose monitoring devices.
COVID-19Impact on Market: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Continuous Glucose Monitoring Systems Market Trends and Drivers:
The market is primarily driven by the increasing geriatric population that is more susceptible to diabetes. In addition, the extensive product utilization for identifying hyperglycemic and hypoglycemia situations in real-time is contributing to the market growth.
Besides this, advancements in CGMS technology that help detect glycated hemoglobin (Hb1ac) in diabetic patients are also positively impacting market growth.
Moreover, the integration of artificial pancreas device systems with CGMS technology for pumping insulin and administering optimum dosage to manage the blood sugar level of patients and the escalating demand for less or minimally invasive diagnostic tools are creating a positive outlook for the market.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market
| Continuous Glucose Monitoring Systems Market Report Scope | |
| Report Coverage | Details |
| Market size value in 2021 | US$ 5.46 Billion |
| Market forecast in 2027 | US$ 9.56 Billion |
| Growth Rate | CAGR of 9.50% from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
Global Continuous Glucose Monitoring Systems Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.
The report has segmented the market on the basis of region, component, demographics and end user.
Breakup by Component:
- Sensors
- Transmitters and Receivers
- Integrated Insulin Pumps
Breakup by Demographics:
- Child Population (≤14 years)
- Adult Population (>14 years)
Market Breakup by End User:
- Clinics and Diagnostics Centers
- ICUs
- Home Healthcare
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Read Also : High Performance Computing (HPC) Market Size, Share 2022-2027
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
